CTLA4 and neoplasm: Furthermore, when these poxvirus-based immunotherapy candidates were used in combination with CTLA-4 blockade, increased lymphocyte proliferation, IFNγ production, and T cell avidity resulted in tumor rejection through immune responses to self-antigens in tolerant mouse models [39–41].